Abstract:Objective To explore possible markers associated with the prognosis of STEMI to provide metabolomic evidence for the benefits of early access to occlusive coronary arteries.Method Forty-three STEMI patients were included and divided into groups A and B, according to the time of vascular opening and the occurrence of cardiac events during the hospitalization and discharge follow-up period (1 month). A dried blood spot method integrated with direct infusion mass spectrometry (MS) metabolomic analysis was applied for the detection of metabolite toward patients with STEMI at admission, first days after PCI,and 1 month after PCI; PCA and OPLS-DA were used to construct a differential model to screen related differential metabolites. The LVEF of the two groups was recorded during postoperative hospital stay and followed up 1 month after PCI, and its correlation with differential metabolites was analyzed.Result The average length of hospital stay in group A was shorter than that in group B, and the rate of heart failure and arrhythmia was lower than that in group B (P < 0.05); PCA model showed that the clustering trend of metabolites was obvious 1 month after PCI, after further OPLS-DA analysis, 14 differential metabolites were screened, including 4 amino acids and 10 carnitine; The metabolites were negatively correlated with LVEF.Conclusions The earlier you open STEMI patients with occluded coronary arteries, the less likely you are to have AEs with cardiac dysfunction; myocardial ischemia and hypoxia lasted a long time, and the content of valine (branched amino acid) and acylcarnitine in blood was relatively high. High metabolites may be related to cardiac dysfunction after myocardial infarction.